Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Change in Accured Expenses (2017 - 2025)

Historic Change in Accured Expenses for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to $30000.0.

  • Catheter Precision's Change in Accured Expenses rose 11265.82% to $30000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $66000.0, marking a year-over-year increase of 12332.16%. This contributed to the annual value of -$185000.0 for FY2024, which is 9740.86% up from last year.
  • Latest data reveals that Catheter Precision reported Change in Accured Expenses of $30000.0 as of Q3 2025, which was up 11265.82% from -$91000.0 recorded in Q2 2025.
  • Catheter Precision's Change in Accured Expenses' 5-year high stood at $5.0 million during Q4 2022, with a 5-year trough of -$5.1 million in Q1 2023.
  • Its 5-year average for Change in Accured Expenses is -$299473.7, with a median of -$83000.0 in 2023.
  • In the last 5 years, Catheter Precision's Change in Accured Expenses skyrocketed by 520357.14% in 2021 and then plummeted by 85454.55% in 2023.
  • Catheter Precision's Change in Accured Expenses (Quarter) stood at $1.5 million in 2021, then soared by 239.19% to $5.0 million in 2022, then plummeted by 100.93% to -$47000.0 in 2023, then surged by 208.51% to $51000.0 in 2024, then plummeted by 41.18% to $30000.0 in 2025.
  • Its last three reported values are $30000.0 in Q3 2025, -$91000.0 for Q2 2025, and $76000.0 during Q1 2025.